Skip to main content

Table 3 Changes in the Roland-Morris Disability, McGill Pain and SF-12 questionnaires between groups at follow-up (N = 501)

From: Effectiveness of a multidisciplinary BIOPSYCHOSOCIAL intervention for non-specific SUBACUTE low back pain in a working population: a cluster randomized clinical trial

 

Control Group (n = 239)

Intervention Group (n = 262)

Difference (95%CI) between group (IG - CG)

Value

Difference*(95% CI)

Value

Difference*(95% CI)

change IG - CG

P-value

Adjusted difference**

P-value

RMDQ, mean (SD)

 Baseline

9.9 (5.3)

 

10.0 (5.2)

     

 three months

7.4 (5.5)

−2.3 (−3.1 to −1.6)

6.2 (4.9)

−3.8 (−4.5 to −3.2)

−1.5 (− 2.5 to −0.5)

0.003*

−1.33 (− 2.22 to − 0.45)

0.005*

 12 months

6.0 (5.7)

−3.8 (− 4.8 to − 2.9)

5.1 (4.9)

−5.1 (−5.8 to − 4.3)

− 1.2 (− 2.4 to − 0.0)

0.043*

−1.11 (− 2.08 to − 0.13)

0.027*

MPQ

 Total intensity score, mean (SD)

  Baseline

6.5 (3.1)

 

6.7 (3.1)

     

  three months

4.6 (3.6)

−1.8 (−2.3 to − 1.3)

4.0 (3.6)

− 2.7 (− 3.2 to − 2.2)

− 0.9 (− 1.6 to − 0.1)

0.022*

−0.49 (− 1.39 to 0.42)

0.294

  12 months

3.6 (3.6)

−2.8 (− 3.3 to − 2.2)

3.1 (3.2)

−3.6 (− 4.1 to − 3.0)

− 0.8 (− 1.6 to 0.0)

0.040*

−0.69 (− 1.41 to 0.02)

0.058**

 Current Intensity score mean (SD)

  Baseline

2.6 (1.1)

 

2.5 (1.2)

     

  three months

1.7 (1.5)

−0.9 (− 1.1 to − 0.7)

1.3 (1.4)

−1.2 (− 1.4 to − 1.0)

−0.3 (− 0.6 to 0.0)

0.083

−0.32 (− 0.63 to − 0.02)

0.040*

  12 months

1.6 (1.4)

−1.1 (− 1.3 to 0.8)

1.4 (1.3)

−1.1 (− 1.3 to − 0.9)

0.0 (−0.3 to 0.3)

0.854

−0.18 (− 0.43 to 0.08)

0.162

 VAS, mean (SD)

  Baseline

5.9 (2.3)

 

5.8 (2.3)

     

  three months

4.1 (3.3)

−1.8 (−2.2 to − 1.3)

3.2 (3.2)

− 2.7 (−3.1 to − 2.2)

−0.9 (− 1.6–0.3)

0.004*

−0.77 (− 1.53 to − 0.01)

0.046*

  12 months

3.9 (3.2)

−2.0 (− 2.5 to − 1.5)

3.6 (3.0)

−2.3 (− 2.7 to − 1.9)

− 0.3 (− 0.9 to 0.4)

0.404

−0.27 (− 0.88 to 0.34)

0.374

 SF-12 Physical health, mean (SD)

  Baseline

40.7 (9.3)

 

41.9 (9.0)

     

  three months

45.3 (9.8)

4.2 (2.7 to 5.6)

46.5 (8.7)

4.5 (3.2 to 5.8)

0.4 (− 1.6 to 2.3)

0.716

0.55 (− 1.19 to 2.29)

0.520

  12 months

46.2 (9.5)

5.0 (3.3 to 6.7)

47.0 (8.9)

4.9 (3.5 to 6.3)

−0.1 (−2.3 to 2.1)

0.922

0.53 (−1.20 to 2.27)

0.532

 SF-12 Mental health, mean (SD)

  Baseline

42.3 (12.4)

 

43.4 (12.8)

     

  three months

45.0 (13.2)

2.6 (0.7 to 4.6)

48.8 (12.0)

5.1 (3.4 to 6.9)

2.5 (−0.1 to 5.0)

0.061

2.56 (− 0.33 to 5.45)

0.082

  12 months

47.0 (11.9)

5.0 (2.9 to 7.1)

48.9 (11.2)

5.5 (3.6 to 7.5)

0.5 (−2.3 to 3.4)

0.707

1.48 (−0.86 to 3.83)

0.206

  1. Abbreviations: SD standard deviation, CI confidence interval, RMDQ Roland-Morris Disability Questionnaire (scale 0–24; lower scores indicate less disability), MGPQ McGill pain questionnaire; 3 dimensions (sensorial, affective and evaluative) with Total Intensity Score (scale 0–14), Current Intensity Score (scale 0–5) and Visual Analogical Scale (VAS, scale 0–10); SF-12 = 12-item short-form health survey version 1 (scale 0–100; lower scores indicate worse health related quality of life). * Differences were calculated between follow-up and baseline measurements. Mean differences are shown for quantitative outcomes and percentage differences for dichotomous outcomes. **All models were adjusted for the score at baseline, significant confounders and significant interaction variables. Intervention group minus usual care group, mean differences are shown for quantitative outcomes and odds ratios for dichotomous outcomes. Intervention group minus usual care group, mean differences are shown for quantitative outcomes and odds ratios for dichotomous outcomes. Total Intensity Score, VAS Pain Score and Mental Health were estimated with a mixed model considering the PHCC as random effect